Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kymera Therapeutics Inc shares valued at $68,239 were sold by Chiniara Ellen on Mar 03 ’25. At $30.45 per share, Chiniara Ellen sold 2,241 shares. The insider’s holdings dropped to 80,085 shares worth approximately $2.0 million following the completion of this transaction.
Also, Chadwick Jeremy G sold 1,383 shares, netting a total of over 42,113 in proceeds. Following the sale of shares at $30.45 each, the insider now holds 67,800 shares.
Before that, Jacobs Bruce N. had sold 7,035 shares from its account. In a trade valued at $214,219, the Chief Financial Officer traded Kymera Therapeutics Inc shares for $30.45 each. Upon closing the transaction, the insider’s holdings decreased to 7,035 shares, worth approximately $5.05 million.
As published in their initiating research note from Citigroup on March 13, 2025, Kymera Therapeutics Inc [KYMR] has been a Buy and the price target has been revised to $52. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of December 06, 2024, BMO Capital Markets has initiated its “Market perform” rating for KYMR. Earlier on December 02, 2024, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for KYMR stock which previously was a “an Equal weight”.
Analyzing KYMR Stock Performance
During the last five days, there has been a surge of approximately 4.47%. Over the course of the year, Kymera Therapeutics Inc shares have dropped approximately -37.81%. Shares of the company reached a 52-week high of $45.31 on 01/27/25 and a 52-week low of $19.44 on 04/09/25. A 50-day SMA is recorded $31.50, while a 200-day SMA reached $40.95.
Support And Resistance Levels for Kymera Therapeutics Inc (KYMR)
According to the 24-hour chart, there is a support level at 24.48, which, if violated, would cause prices to drop to 23.93. In the upper region, resistance lies at 25.51. The next price resistance is at 26.00. RSI (Relative Strength Index) is 41.22 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.75, which suggests the price will decrease in the coming days. Percent R is at 49.16%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
